Peptide Specialty Laboratories (PSL) GmbH was founded in August 2000 as a spin-off company of the German Cancer Research Center (DKFZ) in Heidelberg, Germany. The company is located within the Technology Park Heidelberg in direct neighborhood of university institutes, university hospitals, and other biotech companies.
The major goals of the PSL GmbH are the production and marketing of peptides, peptide analogues, bioconjugates, and peptide specific antisera. Dr. Hans-Richard Rackwitz, one of the cofounders and manager of the PSL GmbH, has many years of experience in the field of peptide synthesis and antibody production, which is well documented in a large number of publications.
The instrumentation of PSL GmbH allows the simultaneous syntheses of up to 144 peptides with a chain length of up to 30 amino acids. Highly optimized synthesizers are set up to yield peptide amounts of up to one gram. These synthesizers also enable the syntheses of peptides with chain lengths of 50 or more amino acids.
Furthermore, services of PSL GmbH include the purification of the peptides by HPLC as well as HPLC analysis and MALDI-TOF mass spectrometry for synthesis and purity control. Our main customers are found within the industry and the research community of Germany and the European Community but we also serve any customer around the world.